Tanai Therapeutics
About:
Therapeutics for obesity and obesity-related conditions.
Top Investors: Novo Nordisk, BioGeneration Ventures, VIB, V-Bio Ventures, Qbic Fund
Description:
Tanai Therapeutics develops novel therapeutics for people living with obesity and obesity-related complications.
Total Funding Amount:
6M EUR
Headquarters Location:
Gent, Oost-Vlaanderen, Belgium
Founded Date:
2023-01-01
Founders:
Number of Employees:
Last Funding Date:
2024-09-19
IPO Status:
Private
Industries:
© 2025 bioDAO.ai